Zentalis Pharmaceuticals Inc (ZNTL)
12.56
+0.04
(+0.32%)
USD |
NASDAQ |
May 10, 16:00
12.56
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Cash from Financing (Quarterly): 0.007M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.007M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.309M |
| June 30, 2023 | 236.62M |
| March 31, 2023 | 0.373M |
| December 31, 2022 | 49.74M |
| September 30, 2022 | 0.589M |
| June 30, 2022 | 209.46M |
| March 31, 2022 | 1.258M |
| December 31, 2021 | 12.27M |
| September 30, 2021 | 166.57M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.316M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.594M |
| September 30, 2020 | 155.90M |
| June 30, 2020 | 191.66M |
| March 31, 2020 | 13.47M |
| December 31, 2019 | -0.053M |
| September 30, 2019 | 81.88M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.594M
Minimum
Dec 2020
236.62M
Maximum
Jun 2023
55.96M
Average
0.9235M
Median
Cash from Financing (Quarterly) Benchmarks
| Revolution Medicines Inc | 839.35M |
| Day One Biopharmaceuticals Inc | 0.048M |
| Perspective Therapeutics Inc | 0.352M |
| Electromed Inc | 0.026M |
| Xtant Medical Holdings Inc | 0.325M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -51.97M |
| Cash from Investing (Quarterly) | 61.54M |
| Free Cash Flow | -211.14M |
| Free Cash Flow Per Share (Quarterly) | -0.7306 |
| Free Cash Flow to Firm (Quarterly) | -52.01M |
| Free Cash Flow Yield | -24.59% |